Stocks making the biggest moves premarket: Exxon Mobil, Chevron, Amazon and others

Stocks making the biggest moves premarket: Exxon Mobil, Chevron, Amazon and others


News Update – Pre-Markets

Check out the companies making headlines before the bell:

Exxon Mobil (XOM) – Exxon Mobil added 2.2% in premarket trading after record profits exceeded analyst forecasts. Higher natural gas prices and cost controls helped offset the slide in crude oil prices.

Chevron (CVX) – Chevron rose 1.7% in premarket action after top and bottom line beats for its latest quarter. Chevron’s $11.2 billion profit was lower than the record $11.6 billion it reported during the prior quarter, but still the second-best on record.

Amazon (AMZN) – Amazon slumped 12.3% in the premarket after projecting much weaker-than-expected revenue for the current quarter. Amazon’s projection reflects economic uncertainty and a significant hit from a stronger U.S. dollar.

Apple (AAPL) – Apple beat top and bottom line estimates for its latest quarter, with its highest revenue ever for the July through September period. However, iPhone sales during the quarter were slightly below Street forecasts. Apple added 1% in premarket trading.

Pinterest (PINS) – Pinterest surged 9.6% in the premarket after its quarterly results beat analyst forecasts and its monthly user numbers also topped expectations.

Intel (INTC) – Intel rallied 6.9% in premarket action despite cutting its full-year sales forecast. The chip maker beat top and bottom line estimates for its latest quarter and said it will focus on cost reductions over the next year.

Sanofi (SNY) – Sanofi shares gained 2.5% in premarket action after the French drug maker issued an upbeat forecast. Sanofi is seeing strong demand for its Dupixent eczema treatment and its flu vaccines.

T-Mobile (TMUS) – T-Mobile shares jumped 3.3% in premarket trading after it reported the strongest jump in subscriber numbers since its merger with Sprint in 2020.

Deckers Outdoor (DECK) – The footwear and apparel maker reported a quarterly profit of $3.80 per share, 12 cents above estimates. The company reaffirmed its full-year outlook and that conservative forecast helped push the stock down 6% in the premarket.



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More